PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 106 trials

Enrolling now

Nationwide

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Cancer Institute (NCI)

Ph 2·~5yr·1 site in MD

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase 1 Trial of TORL-4-500 in People with Advanced Cancer

TORL Biotherapeutics, LLC

Ph 1·~3yr·8 sites in AZ, CA, FL +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Pilot Trial to Assess PYLARIFY PET-CT for Detecting Metastasis

M.D. Anderson Cancer Center

Ph 1·~4yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Inova Health Care Services

Ph 2/3·~3yr·2 sites in VA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis

Genentech, Inc.

Ph 2·~2yr·60 sites in AZ, CA, CO +21

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Eli Lilly and Company

Ph 1·~7yr·20 sites in CA, FL, IN +10

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Trial Using 18F-FS PG PET

M.D. Anderson Cancer Center

Ph 1·~7yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

University of Florida

Ph 2·1 site in FL

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

GNS561 and Trametinib Trial for Liver Cancer

Genfit

Ph 1/2·~3yr·10 sites in CA, FL, IL +5

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Combination of TATE and PD-1 Inhibitor in Liver Cancer

Teclison Ltd.

Ph 2·~9yr·3 sites in CA, OK, WI

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Eureka Therapeutics Inc.

Ph 1/2·~6yr·2 sites in CA, MA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

AZD9793 Trial for Liver Cancer

AstraZeneca

Ph 1/2·~3yr·6 sites in CA, MD, MO +2

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

IDOV-Immune Trial

ViroMissile, Inc.

Ph 1·~2yr·3 sites in MO, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Baylor College of Medicine

Ph 1·~18yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Seattle Children's Hospital

Ph 1·~18yr·1 site in WA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Interventional Radiology and Radiation Therapy for Liver Cancer

Duke University

~6yr·2 sites in NC

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Liver Cancer Disparities in American Indian and Alaska Native Persons

University of Washington

Ph 2·~4yr·1 site in OK

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

VA Office of Research and Development

~8yr·17 sites in CA, CO, CT +10

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

REGULUS Trial

Stanford University

Procedure·Ph 2·~4yr·1 site in CA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

University of California, Irvine

Ph 2·1 site in CA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

AstraZeneca

Ph 2·~5yr·10 sites in AL, CA, FL +5

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

TransThera Sciences (Nanjing), Inc.

Ph 3·~3yr·19 sites in CA, FL, IL +10

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

T-Cell Therapy (ECT204) in Adults With Advanced HCC

Eureka Therapeutics Inc.

Ph 1/2·~6yr·6 sites in CA, KS, NY +3

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

TCF-001 TRACK (Target Rare Cancer Knowledge) Trial

TargetCancer Foundation

~5yr·1 site in MA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify